Research study Program year 2021 Source: CMS Open Payments

Lnf-021

Research payments

$629,510

9 payments

Through program year 2021, $629,510 in research payments was reported against Lnf-021, across 9 payments, paid by Eiger BioPharmaceuticals, Inc..

Paid by: Eiger BioPharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$629,510	9

Breakdown

Who paid Research payments · program year 2021

Eiger BioPharmaceuticals, Inc. $629,510 9 payments

Who received the money Research payments · program year 2021

Axis Clinicals LLC Organisation paid for research $629,510 9 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program year 2021

Patient care $408,726 1 payment
Other $137,385 3 payments
Overhead $51,088 2 payments
Non-patient care $32,311 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

Swarna Yadlapalli Fargo, ND Named on 9 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.